Verastem (VSTM) EPS (Weighted Average and Diluted) (2018 - 2025)
Verastem has reported EPS (Weighted Average and Diluted) over the past 8 years, most recently at -$0.29 for Q4 2025.
- Quarterly results put EPS (Weighted Average and Diluted) at -$0.29 for Q4 2025, up 81.29% from a year ago — trailing twelve months through Dec 2025 was -$3.22 (up 13.44% YoY), and the annual figure for FY2025 was -$3.02, up 17.49%.
- EPS (Weighted Average and Diluted) for Q4 2025 was -$0.29 at Verastem, up from -$1.35 in the prior quarter.
- Over the last five years, EPS (Weighted Average and Diluted) for VSTM hit a ceiling of -$0.08 in Q1 2023 and a floor of -$4.59 in Q4 2021.
- Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.61 (2024), compared with a mean of -$0.98.
- Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 3725.0% in 2021 and later skyrocketed 81.29% in 2025.
- Verastem's EPS (Weighted Average and Diluted) stood at -$4.59 in 2021, then increased by 6.97% to -$4.27 in 2022, then soared by 75.88% to -$1.03 in 2023, then crashed by 50.49% to -$1.55 in 2024, then soared by 81.29% to -$0.29 in 2025.
- The last three reported values for EPS (Weighted Average and Diluted) were -$0.29 (Q4 2025), -$1.35 (Q3 2025), and -$0.62 (Q2 2025) per Business Quant data.